Fig. 1From: Observational long-term follow-up study of rapid food oral immunotherapy with omalizumabTimeline of original phase 1 trial and long-term follow-up study. Zero depicts the time at which the participant reached their 2 g maintenance dose during the original phase 1 trialBack to article page